Concert Pharmaceuticals to Present at Upcoming Investor Conferences
08 Septiembre 2020 - 6:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will participate at the following upcoming virtual investor
conferences:
- The H.C. Wainwright 22nd Annual Global Investment Conference on
September 14, 2020 at 2:30 p.m. EDT; and
- The Cantor Virtual Global Healthcare Conference on September
17, 2020 at 12:00 p.m. EDT.
Live webcasts of the presentations may be accessed in the
Investors section of the Company’s website at
www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the conference webcasts will be available on Concert’s
website for two weeks following the presentations.
About Concert
Concert Pharmaceuticals is a clinical stage biopharmaceutical
company focused on applying its DCE Platform® (deuterated chemical
entity platform) to create novel medicines designed to treat
serious diseases and address unmet patient needs. The Company’s
approach starts with previously studied compounds, including
approved drugs, in which deuterium substitution has the potential
to enhance clinical safety, tolerability or efficacy. Concert’s
pipeline of innovative medicines targets autoimmune diseases and
central nervous systems (CNS) disorders. For more information
please visit www.concertpharma.com or follow us on Twitter at
@ConcertPharma or on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200908005063/en/
Justine Koenigsberg (781) 674-5284 ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Concert Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Concert Pharmaceuticals, Inc. Artículos de Noticias